It's a decision no woman wants to have to make, but new research shows that young breast cancer patients with high-risk genes ...

New research shows that young breast cancer patients with high-risk genes may be able to prevent their cancer from returning ...

Several biomarkers may predict improved treatment responses and outcomes in patients with triple-negative breast cancer.

The ZEST clinical trial, designed to evaluate niraparib (Zejula) for the prevention of breast cancer recurrence in patients ...